SCHEMBL10113625

SCHEMBL10113625

CC(C)(C)S(=O)(=O)NCCCCC(=O)Nc1ccc(Oc2ccncc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
HDAC6 Q9UBN7 7/20 0.46
HDAC3 O15379 6/20 0.46
HDAC4 P56524 6/20 0.46
HDAC1 Q13547 6/20 0.46
HDAC7 Q8WUI4 6/20 0.46
HDAC2 Q92769 6/20 0.46
HDAC10 Q969S8 6/20 0.46
HDAC11 Q96DB2 6/20 0.46
HDAC8 Q9BY41 6/20 0.46
HDAC9 Q9UKV0 6/20 0.46
HDAC5 Q9UQL6 6/20 0.46
HPGD P15428 1/20 0.46
GALR3 O60755 1/20 0.45
RAF1 P04049 4/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
RIPK2 O43353 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10113403 0.89 HDAC6 (0.59) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10115177 0.85 HPGD (0.65) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10113511 0.85 L3MBTL1 (0.68) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10114688 0.84 ALDH1A1 (0.53) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10113497 0.82 L3MBTL1 (0.58) L3MBTL1ALDH1A1LMNA
SCHEMBL10114981 0.82 TP53 (0.55) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10115026 0.81 ALDH1A1 (0.68) ALDH1A1LMNAHDAC6HDAC3HDAC4
SCHEMBL10115072 0.81 ALDH1A1 (0.54) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10113440 0.81 ALDH1A1 (0.54) L3MBTL1ALDH1A1LMNAHDAC6HDAC3
SCHEMBL10113642 0.80 ALDH1A1 (0.51) L3MBTL1ALDH1A1LMNAHDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R L3MBTL1 2541/4885ALDH1A1 4599/4885LMNA 2068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.